SNMMI has released a new appropriate use criteria (AUC) for bone scintigraphy in prostate and breast cancer.
This is the first in a series of new AUC developed by SNMMI in its role as a qualified provider-led entity (PLE) under the Medicare Appropriate Use Criteria Program for advanced diagnostic imaging. These AUC are intended to assist referring physicians and ordering professionals to fulfill the requirements of the 2014 Protecting Access to Medicare Act (PAMA).